Pfizer/GSK Unveiling HIV Joint Venture As ViiV Healthcare
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer and GlaxoSmithKline on Nov. 3 will formally unveil their much-ballyhooed HIV joint venture, announced last April.
You may also be interested in...
GSK Reviews Options For European Business, Adopts New Manufacturing Processes
GlaxoSmithKline will implement a new £1.5 billion restructuring program to improve commercial efficiencies in Europe and adopt new manufacturing processes, following sales and profits shortfalls in 2012.
FDA's Handling Of Byetta Pancreatitis Risk Could Bode Well For Other Diabetes Drugs
Amylin's Byetta cleared for first-line use without a black box stigma, but sales may still not get a lift.
FDA's Handling Of Byetta Pancreatitis Risk Could Bode Well For Other Diabetes Drugs
Amylin's Byetta cleared for first-line use without a black box stigma, but sales may still not get a lift.